Surgical Outcome of Trigeminal Schwannomas.
neurosurgical oncology
operative technique
schwannoma
skull base
trigeminal nerve
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Mar 2021
15 Mar 2021
Historique:
received:
01
03
2021
revised:
12
03
2021
accepted:
13
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
(1) Background: As resection of trigeminal schwannomas is challenging, due to anatomical involvement of the anterior, middle and posterior fossa, the appropriate approach is important. We report our experience with surgical resection of trigeminal schwannomas by simple and classic skull-base approaches. (2) Methods: We performed a retrospective single-center study including patients who underwent surgery for trigeminal schwannoma tumors between June 2007 and May 2020, concentrating on surgical technique, extent of resection, postoperative outcome and complications. (3) Results: We included 13 patients (median age 57.5 with range of 36-83 years, 53.8% (7/13) female. The most common preoperative clinical presentations were facial pain in six (46.2%), hypoacusis in four (30.8%), trigeminal nerve hypesthesia in 11 (V1 46.2% (6/13), V2 (61.5% (8/13), V3 46.2% (6/13)) and headache in three (23.1%) patients. In three cases, the tumor was resected in a two-stage technique. The intradural subtemporal approach was performed in six cases, the extradural technique in two cases, the retrosigmoid approach in five cases, a Kawase approach in two cases and the transnasal endoscopic approach in one case. The gross total resection rate was 76.9% (10/13) and the median follow-up time 24.0 (0-136) months. Three (23.1%) patients developed postoperative anesthesia in at least one branch of the trigeminal nerve. Trigeminal motor function was preserved in 11 (84.6%) patients. Ten of the 11 patients (76.9%) who reported decreased gustation, cerebellar ataxia, visual impairment, or headache improved postoperatively. Two (15.4%) patients exhibited minimal facial palsy (House and Brackmann II-III), which resolved during the follow-up. The total adverse event rate requiring surgical intervention during follow-up was 7.7%. Surgery-related mortality was 0%. (4) Conclusions: Trigeminal schwannomas are rare benign lesions with intra- and extracranial extension. Considering the low operative morbidity and satisfying functional outcome, gross total resection of trigeminal schwannomas is achievable by classic, but also individually tailored approaches. More invasive or combined techniques were not needed with meticulous surgical planning.
Identifiants
pubmed: 33804067
pii: cancers13061310
doi: 10.3390/cancers13061310
pmc: PMC8002014
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurosurg. 2007 Jan;106(1):18-23
pubmed: 17236483
J Neurosurg. 2016 Dec;125(6):1472-1482
pubmed: 27035174
Clin Neurosurg. 1953;1:11-54
pubmed: 14379464
J Neurosurg. 1987 Oct;67(4):488-99
pubmed: 3655886
J Neurosurg. 2002 Mar;96(3):453-63
pubmed: 11883829
Neurosurg Rev. 2010 Apr;34(2):159-71
pubmed: 20963463
Neurosurg Rev. 2007 Oct;30(4):329-37; discussion 337
pubmed: 17676346
Br J Neurosurg. 2008 Dec;22(6):729-38
pubmed: 19085355
Neurosurgery. 2006 Oct;59(4 Suppl 2):ONS270-7; discussion ONS277-8
pubmed: 17041497
Neurosurg Focus. 2014;37(4):E17
pubmed: 25270136
Neurosurgery. 2004 Jun;54(6):1385-93; discussion 1393-4
pubmed: 15157295
Neurosurgery. 2007 Mar;60(3):460-8; discussion 468-70
pubmed: 17327790
Neurosurg Focus. 2008;25(6):E6; discussion E6
pubmed: 19035703
Acta Neurochir (Wien). 2007;149(9):959-63; discussion 964
pubmed: 17534571
Br J Neurosurg. 2014 Jan;28(1):16-9
pubmed: 24350733
Br J Neurosurg. 2002 Oct;16(5):448-55
pubmed: 12498487
J Neurosurg. 2019 Jun 21;133(2):467-476
pubmed: 31226689
Cancer. 2009 Jan 15;115(2):390-8
pubmed: 19109818
Neurosurgery. 2012 Aug;71(2):270-7; discussion 277
pubmed: 22472550
Cancers (Basel). 2020 Mar 31;12(4):
pubmed: 32244314
J Neurosurg. 2010 Nov;113(5):1079-84
pubmed: 19895193
J Neurosurg. 1999 Aug;91(2):202-11
pubmed: 10433308
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1115-21
pubmed: 24267973
J Neurol Surg B Skull Base. 2016 Aug;77(4):371-8
pubmed: 27441164
Otol Neurotol. 2007 Dec;28(8):1083-90
pubmed: 18043434
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Radiother Oncol. 2015 Mar;114(3):378-83
pubmed: 25702864
Stereotact Funct Neurosurg. 2013;91(4):236-42
pubmed: 23548989
J Neurosurg. 1995 May;82(5):719-25
pubmed: 7714595
Radiother Oncol. 2013 Feb;106(2):175-80
pubmed: 23333012
Neurochirurgie. 2018 Nov;64(5):364-369
pubmed: 26071178
Neurosurgery. 1998 Feb;42(2):233-40; discussion 240-1
pubmed: 9482173
Acta Neurochir (Wien). 1994;130(1-4):55-65
pubmed: 7725943
Laryngoscope. 2008 Feb;118(2):195-203
pubmed: 18090871
World Neurosurg. 2018 Nov;119:e874-e881
pubmed: 30099184
Acta Neurochir (Wien). 1986;82(3-4):118-22
pubmed: 3491493
Br J Neurosurg. 2021 Feb;35(1):49-56
pubmed: 32628557
Cancers (Basel). 2019 Sep 16;11(9):
pubmed: 31527541
BMJ Open. 2013 Feb 22;3(2):
pubmed: 23435793
J Neurosurg. 1995 May;82(5):711-8
pubmed: 7714594
Neurosurgery. 2003 Apr;52(4):783-90; discussion 790
pubmed: 12657173
Acta Neuropathol. 2020 Apr;139(4):643-665
pubmed: 31161239